Eicosis, LLC logo

Eicosis, LLC

EicOsis is a privately held company developing a first-in-class therapy of a once daily, oral treatment for neuropathic and inflammatory pain in humans and companion animals.

EicOsis technology for the lead compounds was developed at the University of California Davis by EicOsis CEO and UC professor, Dr. Bruce Hammock and licensed exclusively to EicOsis from the University of California, Davis.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.eicosis.com
Founded2010
Disease Focus
Development Stage
STOCK CODENon Listed
Address
1407 Nutmeg Ln, CA 95618
Davis
United States
Email
Contact Number
+1 650 455 0388

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]

In Jan 2016, EicOsis, was awarded with The National Institutes of Health (NIH) Blueprint for Neuroscience Research (Blueprint) grant totaling over $4 Mn to advance compounds through Phase 1 clinical trials for diabetic neuropathic pain.